What does it take to turn groundbreaking science into life-saving treatments?

In this episode of Defining the Future, Claire Rutherford is joined by Prof Carrie Ambler. Carrie is a Professor at Durham University and the Chief Scientific Officer at LightOx Ltd, a pioneering company dedicated to developing novel chemicals for targeted phototherapies, particularly for oral cancer and wound care.

Since founding LightOx in 2016, Carrie has been instrumental in advancing the company's innovative approach to cancer treatment. Her diverse background, which includes significant experience in the health and life sciences industry, has equipped her with the expertise needed to lead LightOx's scientific and commercial endeavours.

Carrie is deeply involved in all aspects of the business, from investment and clinical trials to regulatory a ...